M. Tuccori

M. Chiarugi, M. Fornai, L. Antonioli, 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

ACE Inhibitors and AT1R Blockers for COVID-2019: Friends or Foes ?

M. Tuccori, D. Focosi, F. Maggi, 2020 .

Clinical Efficacy of Esomeprazole in the Prevention and Healing of Gastrointestinal Toxicity Associated with NSAIDs in Elderly Patients

M. Fornai, L. Antonioli, C. Blandizzi, 2008, Drugs & aging.

Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients

C. Blandizzi, M. Tuccori, I. Convertino, 2020, Critical Care.

An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future

M. Tuccori, I. Convertino, S. Ferraro, 2021, Expert opinion on drug discovery.

Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment.

M. Fornai, L. Antonioli, C. Blandizzi, 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Allergic reactions to oral drugs: A case/non-case study from an Italian spontaneous reporting database (GIF).

R. Leone, U. Moretti, A. Caputi, 2008, Pharmacological research.

Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study

V. Lorenzoni, R. Gini, L. Baglietto, 2021, Journal of clinical medicine.

Drug-Associated QTc Prolongation in Geriatric Hospitalized Patients: A Cross-Sectional Study in Internal Medicine

P. Lazzerini, P. Capecchi, F. Laghi-Pasini, 2021, Drugs - Real World Outcomes.

Convalescent Plasma Therapy for COVID-19: State of the Art

J. Tang, M. Tuccori, D. Focosi, 2020, Clinical Microbiology Reviews.

Hepatitis C virus infection: opportunities for an earlier detection in primary care

F. Lapi, A. Rossi, I. Cricelli, 2017, European journal of gastroenterology & hepatology.

Pathophysiology of Gastric Ulcer Development and Healing: Molecular Mechanisms and Novel Therapeutic Options

M. Fornai, L. Antonioli, C. Blandizzi, 2011 .

The Road towards Polyclonal Anti-SARS-CoV-2 Immunoglobulins (Hyperimmune Serum) for Passive Immunization in COVID-19

M. Franchini, M. Tuccori, D. Focosi, 2021, Life.

Preclinical discovery and development of the casirivimab + imdevimab cocktail for the treatment of novel coronavirus infection: the rise and fall

M. Franchini, M. Tuccori, I. Convertino, 2022, Expert opinion on drug discovery.

Reply to the Letter to the Editor on ‘Cost-opportunity analysis in clinical oncology: from the “wild far-west” to a correct integration of the disciplines, avoiding the “war of the worlds”’, by D. Tassinari et al. (Ann Oncol 2006; 17: 876)

R. Kerbel, G. Bocci, A. Falcone, 2006 .

Monoclonal antibody therapies against SARS-CoV-2

A. Casadevall, M. Tuccori, E. Cappello, 2022, The Lancet Infectious Diseases.

Esomeprazole-induced hyperchromograninemia in the absence of concomitant hypergastrinemia

C. Blandizzi, M. Tuccori, C. Spinelli, 2010, Nature Reviews Gastroenterology &Hepatology.

Autoimmune Hemolytic Anemia Following MF59-Adjuvanted Influenza Vaccine Administration: A Report of Two Cases

C. Blandizzi, S. Mantarro, M. Tuccori, 2011, The Annals of pharmacotherapy.

Adverse reactions to oncologic drugs: spontaneous reporting and signal detection

M. Fornai, L. Antonioli, C. Blandizzi, 2015, Expert review of clinical pharmacology.

SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies

A. Baj, M. Tuccori, D. Focosi, 2021, Viruses.

Developing a Crowdsourcing Approach and Tool for Pharmacovigilance Education Material Delivery

M. Lindquist, A. Bate, E. V. van Puijenbroek, 2017, Drug Safety.

Re: Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.

C. Blandizzi, M. Tuccori, D. Focosi, 2009, Journal of the National Cancer Institute.

Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage

S. Baldi, M. Fornai, L. Antonioli, 2005, Naunyn-Schmiedeberg's Archives of Pharmacology.

Progressive multifocal leukoencephalopathy: a report of three cases in HIV-negative patients with non-Hodgkin's lymphomas treated with rituximab

M. Cosottini, C. Blandizzi, M. Tuccori, 2010, Annals of Hematology.

Checkpoint inhibitors and progressive multifocal leukoencephalopathy: friends of foes?

M. Tuccori, D. Focosi, F. Maggi, 2019, Annals of translational medicine.

Pharmacological modulation of adenosine receptor pathways and inflammatory disorders: the way towards novel therapeutics?

M. Fornai, L. Antonioli, C. Blandizzi, 2011, Expert opinion on investigational drugs.

SSRIs and birth defects: can a new statistical approach resolve old controversies?

C. Blandizzi, M. Tuccori, 2016, Evidence-Based Mental Health.

Prescription of Anti-Spike Monoclonal Antibodies in COVID-19 Patients with Resistant SARS-CoV-2 Variants in Italy

M. Tuccori, D. Focosi, 2022, Pathogens.

Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation

R. Brandi, O. Turriziani, G. Antonelli, 2022, Clinical Microbiology and Infection.

Nonsteroidal Anti-Inflammatory Drug-Activated Gene-1 Plays a Role in the Impairing Effects of Cyclooxygenase Inhibitors on Gastric Ulcer Healing

C. Scarpignato, M. Fornai, L. Antonioli, 2012, Journal of Pharmacology and Experimental Therapeutics.

Vaccines Safety in Children and in General Population: A Pharmacovigilance Study on Adverse Events Following Anti-Infective Vaccination in Italy

M. Levi, A. Vannacci, A. Mugelli, 2019, Front. Pharmacol..

The Blockade of Adenosine Deaminase Ameliorates Chronic Experimental Colitis through the Recruitment of Adenosine A2A and A3 Receptors

F. Da Settimo, C. La Motta, M. Fornai, 2010, Journal of Pharmacology and Experimental Therapeutics.

Fatal Hepatitis After Long-Term Pulse Itraconazole Treatment for Onychomycosis

C. Blandizzi, M. Tuccori, M. D. Paolo, 2008, The Annals of pharmacotherapy.

Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review

U. Moretti, M. Franchini, M. Tuccori, 2022, Seminars in Thrombosis and Hemostasis.

Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects

M. Fornai, L. Antonioli, C. Blandizzi, 2016, Drug Safety.

Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy.

M. Fornai, L. Antonioli, C. Blandizzi, 2009, Pharmacological research.

Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications.

M. Fornai, L. Antonioli, C. Blandizzi, 2008, Pharmacology & therapeutics.

Pharmacological modulation of adenosine system: Novel options for treatment of inflammatory bowel diseases

M. Fornai, L. Antonioli, C. Blandizzi, 2008, Inflammatory bowel diseases.

Neuropsychiatric Adverse Events Associated with Statins: Epidemiology, Pathophysiology, Prevention and Management

M. Fornai, L. Antonioli, C. Blandizzi, 2014, CNS Drugs.

Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database.

A. Vannacci, F. Lapi, M. Moschini, 2013, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Transient acute liver failure complicating transurethral resection syndrome

M. Di Paolo, M. Fornai, L. Antonioli, 2010, Scandinavian journal of urology and nephrology.

Gabapentin-Induced Severe Myopathy

A. Vannacci, F. Lapi, C. Blandizzi, 2007, The Annals of pharmacotherapy.

Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders.

F. Da Settimo, C. La Motta, M. Fornai, 2012, Current drug targets.

Involvement of the P2X7 Purinergic Receptor in Colonic Motor Dysfunction Associated with Bowel Inflammation in Rats

C. Scarpignato, C. Pellegrini, M. Fornai, 2014, PloS one.

Drug Safety in Geriatric Patients: Current Status and Proposed Way Forward

M. Tuccori, E. Cappello, G. Valdiserra, 2020, Drug Safety.

The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications.

C. Pellegrini, M. Fornai, L. Antonioli, 2013, Pharmacology & therapeutics.

Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline

C. Blandizzi, M. Tuccori, I. Convertino, 2020, mAbs.

Use of Selective Serotonin Reuptake Inhibitors during Pregnancy and Risk of Major and Cardiovascular Malformations: An Update

A. Pergola, M. Fornai, L. Antonioli, 2010, Postgraduate medicine.

Effects of pantoprazole on ulcer healing delay associated with NSAID treatment

M. Fornai, L. Antonioli, C. Blandizzi, 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety

C. Chiamulera, G. Trifirò, F. Pappalardo, 2021, Drug Safety.

Risk of Hospitalization Associated with Cardiovascular Medications in the Elderly Italian Population: A Nationwide Multicenter Study in Emergency Departments

G. Vighi, A. Vannacci, G. Crescioli, 2021, Frontiers in Pharmacology.

Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study)

G. Vighi, A. Vannacci, A. Mugelli, 2020, Frontiers in Pharmacology.

Use of Biological Drugs for Psoriasis: A Drug-Utilization Study Using Tuscan Administrative Databanks

R. Gini, L. Baglietto, E. Lucenteforte, 2022, International journal of environmental research and public health.

Drug-Induced Taste and Smell Alterations

A. Vannacci, F. Lapi, U. Moretti, 2011, Drug safety.

Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System

U. Moretti, E. Poluzzi, E. Raschi, 2019, Targeted Oncology.

The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes

M. Tuccori, L. Azoulay, H. Yin, 2015, Diabetes Care.

Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders.

M. Bellini, M. Fornai, L. Antonioli, 2015, Pharmacogenomics.

NSAID-Induced Enteropathy: Are the Currently Available Selective COX-2 Inhibitors All the Same?

C. Scarpignato, C. Pellegrini, M. Fornai, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Influence of the Serotonin Transporter 5HTTLPR Polymorphism on Symptom Severity in Irritable Bowel Syndrome

M. Bellini, G. Rossi, M. Fornai, 2013, PloS one.

Emerging role of cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions.

R. De Giorgio, M. Fornai, L. Antonioli, 2010, Pharmacology & therapeutics.

Tolerability Profiles of Leukotriene Receptor Antagonists and Long-Acting β2-Adrenoceptor Agonists in Combination with Inhaled Corticosteroids for Treatment of Asthma: A Review

M. Fornai, L. Antonioli, C. Blandizzi, 2007, The Journal of asthma : official journal of the Association for the Care of Asthma.

Monitoring the manufacturing and quality of medicines: a fundamental task of pharmacovigilance

A. Mangoni, M. D'antuono, Brian D Edwards, 2021, Therapeutic advances in drug safety.

Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: Characterization of molecular mechanisms.

F. Basolo, C. Ugolini, M. Fornai, 2011, Pharmacological research.

Pioglitazone use and risk of bladder cancer: population based cohort study

Robert W Platt, Laurent Azoulay, Kristian B Filion, 2016, British Medical Journal.

Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study)

G. Vighi, A. Vannacci, A. Mugelli, 2021, Internal and Emergency Medicine.

Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database

S. Salvadori, M. Hauben, C. Blandizzi, 2017, Drug Safety.

Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project

M. Massari, G. Trifirò, R. Gini, 2021, BioDrugs.

Inclusion of rituximab in treatment protocols for non-Hodgkin's lymphomas and risk for progressive multifocal leukoencephalopathy.

M. Pistello, G. Rossi, P. Pepe, 2010, The oncologist.

Clinical differences among the elderly admitted to the emergency department for accidental or unexplained falls and syncope

M. Santini, A. Ungar, C. Blandizzi, 2017, Clinical interventions in aging.

Teaching Pharmacovigilance: the WHO-ISoP Core Elements of a Comprehensive Modular Curriculum

M. Lindquist, A. Bate, I. Edwards, 2014, Drug Safety.

Severe thrombocytopenia and haemolytic anaemia associated with ciprofloxacin: A case report with fatal outcome

M. Di Paolo, C. Blandizzi, M. Tuccori, 2008, Platelets.

What is the optimal usage of coronavirus disease 2019 convalescent plasma donations?

G. Antonelli, M. Tuccori, D. Focosi, 2020, Clinical Microbiology and Infection.

Efficacy of High-Dose Polyclonal Intravenous Immunoglobulin in COVID-19: A Systematic Review

M. Franchini, M. Tuccori, D. Focosi, 2022, Vaccines.

Diabetes drugs and the incidence of solid cancers: a survey of the current evidence

C. Blandizzi, M. Tuccori, I. Convertino, 2017, Expert opinion on drug safety.

Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis

V. Lorenzoni, R. Gini, E. Lucenteforte, 2023, Pharmaceuticals.

Allopurinol adherence among patients with gout: an Italian general practice database study

F. Lapi, I. Cricelli, C. Cricelli, 2015, International journal of clinical practice.

Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway

M. Chiarugi, M. Fornai, L. Antonioli, 2007, British journal of pharmacology.

CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon.

M. Fornai, L. Antonioli, C. Blandizzi, 2007, European journal of pharmacology.

Cases of acquired hemophilia A following COVID‐19 vaccines: Cogent safety signal or possible reporting/detection bias? Preliminary evidence from Tuscany, Italy

R. Gini, M. Franchini, M. Tuccori, 2023, Pharmacoepidemiology and drug safety.

Safety Profile of the Fluoroquinolones

G. Mazzaglia, A. Vannacci, F. Lapi, 2010, Drug safety.

Adherence with regulatory resolutions on prevention of NSAIDs-related gastrointestinal injury in Italy

S. Salvadori, C. Scarpignato, C. Blandizzi, 2016, International Journal of Clinical Pharmacy.

Statin-Associated Psychiatric Adverse Events

A. Vannacci, F. Lapi, A. Mugelli, 2008, Drug safety.

Potential Direct Costs of Adverse Drug Events and Possible Cost Savings Achievable by their Prevention in Tuscany, Italy: A Model-Based Analysis

S. Salvadori, C. Blandizzi, M. Tuccori, 2018, Drug Safety.

Guillain-Barré syndrome following adalimumab treatment.

M. Galeazzi, M. Tuccori, M. Rossi, 2012, Clinical and Experimental Rheumatology.

A holistic view of adenosine in the control of intestinal neuromuscular functions: the enteric ‘purinome’ concept

M. Fornai, L. Antonioli, C. Blandizzi, 2011, British journal of pharmacology.

RE: Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch Syndrome.

K. Filion, M. Tuccori, L. Azoulay, 2016, Journal of the National Cancer Institute.

Unresolved gustatory, olfactory and auditory adverse drug reactions to antibiotic drugs: a survey of spontaneous reporting to Eudravigilance

L. Leonardi, C. Blandizzi, M. Tuccori, 2019, Expert opinion on drug safety.

Drug therapeutic failures in emergency department patients. A university hospital experience.

G. Bocci, C. Blandizzi, M. Tuccori, 2004, Pharmacological research.

Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence

M. Tuccori, I. Convertino, S. Ferraro, 2023, Expert opinion on drug discovery.

Is There a Risk of Lymphoma Associated With Anti-tumor Necrosis Factor Drugs in Patients With Inflammatory Bowel Disease? A Systematic Review of Observational Studies

L. Leonardi, C. Blandizzi, M. Tuccori, 2019, Front. Pharmacol..

Quality of Adverse Drug Reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance

A. Vannacci, F. Lapi, M. Fornai, 2013, Journal of Public Health.

An overview of methodological flaws of real-world studies investigating drug safety in the post-marketing setting

G. Trifirò, M. Tuccori, S. Crisafulli, 2023, Expert opinion on drug safety.

Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials

C. Chiamulera, G. Trifirò, A. Vannacci, 2023, Drug Safety.

Other Sources of Information for Monitoring Drug Safety: Now and in the Future

M. Tuccori, M. Wallberg, 2017 .

Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district.

P. Pepe, M. Fornai, L. Antonioli, 2011, Vaccine.